[1] TARIQ R, SYED T, YADAV D, et al. Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: a systematic review and meta-analysis[J]. J Clin Gastroenterol, 2023, 57(3): 285-293.
[2] SONG W, SUN L Y, ZHU Z J, et al. Characteristics of gut microbiota in children with biliary atresia after liver transplantation[J]. Front Physiol, 2021, 12: 704313.
[3] 中华医学会肠外肠内营养学分会,中国人体健康科技促进会肠道微生态与肠菌移植专业委员会,上海市预防医学会肠道微生态专业委员会. 肠菌移植治疗炎症性肠病专家共识(2025版)[J]. 中华胃肠外科杂志,2025,28(3):225-235.
[4] HAIFER C, PARAMSOTHY S, KAAKOUSH N O, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial[J]. Lancet Gastroenterol Hepatol, 2022, 7(2): 141-151.
[5] FOURATI S, DUMAY A, ROY M, et al. Fecal microbiota transplantation in a rodent model of short bowel syndrome: a therapeutic approach?[J]. Front Cell Infect Microbiol, 2023, 13: 1023441.
[6] BUSING J D, FOULADI F, BULIK‐SULLIVAN E C, et al. Gut microbial changes following fecal microbiota transplantation for D‐lactic acidosis in two children[J]. JPGN Rep, 2023, 4(3): e319.
[7] TIAN B, ZHANG Y, DENG C, et al. Efficacy of probiotic consortium transplantation on experimental necrotizing enterocolitis[J]. J Surg Res, 2022, 279: 598-610.
[8] LIU J, MIYAKE H, ZHU H, et al. Fecal microbiota transplantation by enema reduces intestinal injury in experimental necrotizing enterocolitis[J]. J Pediatr Surg, 2020, 55(6): 1094-1098.
[9] LIN H, GUO Q, RAN Y, et al. Multiomics study reveals enterococcus and subdoligranulum are beneficial to necrotizing enterocolitis[J]. Front Microbiol, 2021, 12: 752102.
[10] PRADO C, ABATTI M R, MICHELS M, et al. Comparative effects of fresh and sterile fecal microbiota transplantation in an experimental animal model of necrotizing enterocolitis[J]. J Pediatr Surg, 2022, 57(9): 183-191.
[11] HE Y, DU W, XIAO S, et al. Colonization of fecal microbiota from patients with neonatal necrotizing enterocolitis exacerbates intestinal injury in germfree mice subjected to necrotizing enterocolitis-induction protocol via alterations in butyrate and regulatory T cells[J]. J Transl Med, 2021, 19: 1-12.
[12] 田亚丽,王芳,田东惠,等.粪菌移植对坏死性小肠结肠炎新生小鼠肠道菌Th1/Th2细胞因子表达的影响[J].中国免疫学杂志,2022,38(2):149-153.
[13] 林浩. 粪菌移植改善坏死性小肠结肠炎预后的作用机制研究[D]. 广东:南方医科大学,2022.
[14] JU X, JIANG Z, MA J, et al. Changes in fecal short-chain fatty acids in IBS patients and effects of different interventions: a systematic review and meta-analysis[J]. Nutrients, 2024, 16(11): 1727.
[15] 朱晓明,周川,路晓霞.新生儿肠闭锁行肠吻合术后粪菌移植治疗的护理[J].医学理论与实践, 2021, 34(5):3.
[16] CALDEIRA L F, BORBA H H, TONIN F S, et al. Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis[J]. PLoS One, 2020, 15(9): e0238910.
[17] PORCARI S, BAUNWALL S M D, OCCHIONERO A S, et al. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis[J]. J Autoimmun, 2023, 141: 103036.
[18] FEHILY S R, BASAYAKE C, WRIGHT E K, et al. Fecal microbiota transplantation therapy in Crohn′s disease: systematic review[J]. J Gastroenterol Hepatol, 2021, 36(10): 2672-2686.
[19] OSAKI H, JODAI Y, KOYAMA K, et al. Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection[J]. Fujita Med J, 2021, 7(3): 87-98.
[20] ZHANG L, MA X, LIU P, et al. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis[J]. Exp Biol Med (Maywood), 2021, 246(13): 1563-1575.
[21] 田宏亮,王乐,马春联,等. 肠菌移植治疗肠道菌群失调相关疾病15 000例的长期疗效分析[J]. 中华胃肠外科杂志,2025,28(3):296-303.
[22] MARCELLA C, CUI B, KELLY C R, et al. Systematic review: the global incidence of faecal microbiota transplantation‐related adverse events from 2000 to 2020[J]. Aliment Pharmacol Ther, 2021, 53(1): 33-42.
[23] XIAO P, LI Y, LI X, et al. Long-term safety of fecal microbiota transplantation in Chinese children from 2013 to 2023: a single-center retrospective study[J]. BMC Microbiol, 2025, 25(1): 152.
[24] MONTALTO M, GALLO A, AGNITELLI M C, et al. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients[J]. J Am Geriatr Soc, 2023, 71(11): 3530-3537.
[25] HEMACHANDRA S, RATHNAYAKE S N, JAYAMAHA A A, et al. Fecal microbiota transplantation as an alternative method in the treatment of obesity[J]. Cureus, 2025, 17(1): e76858.
[26] STEFANSSON M, BLADN O, FLINK O, et al. Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial[J]. PLoS One, 2023, 18(9): e0292132.
[27] 戴媛媛, 马筱玲. 宏基因组二代测序技术在临床病原学诊断中的应用[J]. 临床检验杂志, 2021, 39(1): 1-5.
[28] CHIU C Y, MILLER S A. Clinical metagenomics[J]. Nat Rev Genet, 2019, 20(6): 341-355.
[1]李璐,李晓飞,孙悦,等.结直肠癌患者肠道菌群促进Apcmin/+小鼠肠道腺瘤进展的研究[J].天津医科大学学报,2019,25(06):551.
LI Lu,LI Xiao-fei,SUN Yue,et al.Gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in Apcmin/+ mice[J].Journal of Tianjin Medical University,2019,25(06):551.